within Pharmacolibrary.Drugs.ATC.S;

model S01ED01
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.61,
    Cl             = 0.0003716666666666667,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.143,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.02,
    Tlag           = 0,            
    Vdp             = 0.0702,
    k12             = 32.9,
    k21             = 32.9
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>S01ED01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Timolol is a non-selective beta-adrenergic antagonist used primarily to treat elevated intraocular pressure in ocular conditions such as glaucoma and ocular hypertension. It is also used systemically for hypertension, migraine prophylaxis, and occasionally for arrhythmias. Ophthalmic timolol is widely approved and used today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers following single oral administration.</p><h4>References</h4><ol><li><p>Fourtillan, JB, et al., &amp; Girault, J (1981). Pharmacokinetics of oral timolol studied by mass fragmentography. <i>European journal of clinical pharmacology</i> 19(3) 193–196. DOI:<a href=\"https://doi.org/10.1007/BF00561948\">10.1007/BF00561948</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7215417/\">https://pubmed.ncbi.nlm.nih.gov/7215417</a></p></li><li><p>Wilson, TW, et al., &amp; Davies, RO (1982). Timolol and propranolol: bioavailability, plasma concentrations, and beta blockade. <i>Clinical pharmacology and therapeutics</i> 32(6) 676–685. DOI:<a href=\"https://doi.org/10.1038/clpt.1982.223\">10.1038/clpt.1982.223</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7140133/\">https://pubmed.ncbi.nlm.nih.gov/7140133</a></p></li><li><p>Else, OF, et al., &amp; Edwards, IR (1978). Plasma timolol levels after oral and intravenous administration. <i>European journal of clinical pharmacology</i> 14(6) 431–434. DOI:<a href=\"https://doi.org/10.1007/BF00716385\">10.1007/BF00716385</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/738350/\">https://pubmed.ncbi.nlm.nih.gov/738350</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end S01ED01;
